{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:19:03Z","timestamp":1776986343143,"version":"3.51.4"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s258704","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:57:02Z","timestamp":1600981022000},"page":"889-901","source":"Crossref","is-referenced-by-count":11,"title":["<p>Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate\/High-Risk Myelofibrosis: Evidence to Date<\/p>"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Sarah","family":"Bassiony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire N","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donal P","family":"McLornan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ajh.23690","volume":"89","author":"Titmarsh","year":"2014","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/asheducation-2017.1.489","volume":"2017","author":"Harrison","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/HS9.0000000000000001","volume":"1","author":"Naymagon","year":"2017","journal-title":"HemaSphere"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41408-017-0032-9","volume":"7","author":"Tefferi","year":"2017","journal-title":"Blood Cancer J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"ref10","unstructured":"Celgene Corporation Press release. Aug. 16, 2019 \u2013 Summit, N.J. \u2013 Celgene Corporation (NASDAQ: CELG) Today Announced the U.S. Food and Drug Administration (FDA) Has Approved INREBIC\u00ae (Fedratinib) for the Treatment of Adult Patients with Intermediate-2 or High-Risk Primary or Secondary (Post-Polycythemia Vera or Post-Essential Thrombocythemia) Myelofibrosis; 2019."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"Harrison","year":"2012","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1110557","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1182\/blood-2018-99-116289","volume":"132","author":"Palandri","year":"2018","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mayocp.2011.11.001","volume":"87","author":"Tefferi","year":"2012","journal-title":"Mayo Clinic Proc"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","volume":"29","author":"Gangat","year":"2011","journal-title":"JCO"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/s41375-018-0107-z","volume":"32","author":"Tefferi","year":"2018","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1200\/JCO.2018.78.9867","volume":"36","author":"Tefferi","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1038\/leu.2017.169","volume":"31","author":"Passamonti","year":"2017","journal-title":"Leukemia"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ajh.23406","volume":"88","author":"Pardanani","year":"2013","journal-title":"Am J Hematol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2141.2006.06142.x","volume":"134","author":"Cervantes","year":"2006","journal-title":"Br J Haematol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000097463","volume":"117","author":"Tsiara","year":"2007","journal-title":"Acta Haematol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40164-015-0021-2","volume":"4","author":"McMullin","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ajh.21892","volume":"86","author":"Thapaliya","year":"2011","journal-title":"Am J Hematol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1200\/JCO.2009.22.6548","volume":"27","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"JCO"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/leu.2016.300","volume":"31","author":"Tefferi","year":"2017","journal-title":"Leukemia"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00277-015-2435-7","volume":"94","author":"Cervantes","year":"2015","journal-title":"Ann Hematol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1182\/blood-2019-128211","volume":"134","author":"Harrison","year":"2019","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1182\/blood-2019-127119","volume":"134","author":"Mascarenhas","year":"2019","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1182\/blood-2019-122546","volume":"134","author":"Gerds","year":"2019","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/leu.2009.50","volume":"23","author":"Pardanani","year":"2009","journal-title":"Leukemia"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1182\/blood-2009-05-223727","volume":"115","author":"Tyner","year":"2010","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2016-09-740092","volume":"129","author":"Asshoff","year":"2017","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/jcph.1050","volume":"58","author":"Xin","year":"2018","journal-title":"J Clin Pharm"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/leu.2013.71","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/leu.2017.330","volume":"32","author":"Pardanani","year":"2018","journal-title":"Leukemia"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41408-018-0067-6","volume":"8","author":"Tefferi","year":"2018","journal-title":"Blood Cancer J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1200\/JCO.2017.73.4418","volume":"35","author":"Mesa","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Mesa RA, Catalano J, Cervantes F, et al. Dynamic and time-to-event analyses demonstrate marked reduction in transfusion requirements for janus kinase inhibitor-na\u00efve myelofibrosis patients treated with momelotinib compared head to head with ruxolitinib. 2019 ASH Annual Meeting & Exposition. 2019.","DOI":"10.1182\/blood-2019-122506"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/S2352-3026(17)30237-5","volume":"5","author":"Harrison","year":"2018","journal-title":"Lancet Haematol"}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61776","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61776","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:57:10Z","timestamp":1600981030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/evaluating-the-safety-efficacy-and-therapeutic-potential-of-momelotini-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s258704","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}